# Ethical AI Implementation Framework for Healthcare

**Author:** Gopesh Aggarwal
**Roll No:** 2301730158
**Version:** 1.0

---

## 1. Purpose

This document defines a practical framework for the ethical implementation of Generative AI in healthcare organizations. It is intended for hospital administrators, clinical AI teams, compliance officers, and vendors building AI tools for medical use.

The framework translates high-level ethical principles into concrete, checkable controls, and aligns with HIPAA, GDPR, India's DPDP Act 2023, the FDA's SaMD guidance, the WHO ethics guidance for AI in health, and the EU AI Act's high-risk classification for medical AI.

---

## 2. Scope

The framework applies to any system that:

- Uses a Generative AI model (LLM, multimodal model, image generator) in a clinical or patient-facing workflow.
- Processes Protected Health Information (PHI) or clinical data.
- Produces outputs that influence diagnosis, treatment, triage, discharge, documentation, or patient communication.

It does **not** replace local regulatory approval. It supplements it by giving a uniform ethical baseline.

---

## 3. The Seven Principles

### 3.1 Fairness
AI outputs should not discriminate across age, gender, race, or socioeconomic status.

**Controls**
- Bias audits run across demographic subgroups before deployment.
- Training data assessed for representativeness, with gaps documented.
- Per-subgroup performance metrics published in the model card.

### 3.2 Transparency
Clinicians and patients should understand how the AI arrived at a recommendation.

**Controls**
- A model card is published and kept current.
- Clinician-facing explanations (feature attribution, confidence scores) are part of the UI.
- Limitations are disclosed to patients in plain language before AI-assisted care.

### 3.3 Accountability
Clear ownership of AI-driven decisions and a path for redress when harm occurs.

**Controls**
- Human-in-the-loop for all treatment-level recommendations.
- Immutable audit logs for every inference.
- A documented incident response plan, rehearsed at least once a quarter.

### 3.4 Privacy
Patient data must be protected in line with HIPAA, GDPR, and DPDP Act 2023.

**Controls**
- PHI de-identified before training or inference where feasible.
- TLS 1.3 in transit and AES-256 at rest.
- Consent collected, logged, and revocable at any time.

### 3.5 Safety
AI should not cause physical, psychological, or financial harm to patients.

**Controls**
- Prospective clinical validation completed before deployment.
- Known failure modes documented and tested.
- Continuous performance and drift monitoring in production.

### 3.6 Beneficence
The AI must demonstrably improve patient outcomes or clinical workflow.

**Controls**
- A clinical outcome metric is agreed with the medical team.
- Baseline vs AI-assisted performance is measured and reported.
- Real-world benefit is tracked for the first six months after launch.

### 3.7 Autonomy
Patients retain the right to refuse AI-driven decisions and seek human judgment.

**Controls**
- Opt-out available without penalty.
- Informed consent obtained for AI-assisted pathways.
- A human-only alternative is always offered.

---

## 4. Scoring and Risk Classification

Each principle receives a score between 0 and 1 based on the fraction of controls satisfied. The overall ethics score is the mean of the seven principle scores. Risk is classified as:

| Overall score | Risk level |
| --- | --- |
| 0.85 – 1.00 | Low |
| 0.60 – 0.85 | Moderate |
| 0.30 – 0.60 | High |
| 0.00 – 0.30 | Critical |

A system with risk level High or Critical should not be deployed in production without remediation.

---

## 5. Governance

### 5.1 Roles
- **AI Ethics Officer** — owns the framework and the review board.
- **Clinical Lead** — accountable for clinical safety of the AI system.
- **Data Protection Officer** — owns privacy compliance.
- **Patient Representative** — sits on the review board for all deployments affecting patients.

### 5.2 Review Cadence
- Pre-deployment assessment before any pilot.
- 30-day and 90-day post-deployment reviews.
- Annual re-assessment for every system in production.

### 5.3 Transparency Commitments
- Model cards are public where the system affects patients directly.
- An annual transparency report summarizes deployed AI, outcomes, and incidents.

---

## 6. Incident Response

1. **Detect** — monitoring or user-reported.
2. **Contain** — disable or gate the system within one hour of detection.
3. **Assess** — classify severity and affected population.
4. **Notify** — patients, regulators, and internal leadership per severity.
5. **Remediate** — root cause and corrective action.
6. **Learn** — update the framework and runbook.

---

## 7. Procurement Checklist for External AI Vendors

Before any healthcare organization onboards a vendor AI system, request the following:

- [ ] Completed assessment against this framework.
- [ ] Model card covering intended use, training data, and known limits.
- [ ] Evidence of bias audit across subgroups.
- [ ] Clinical validation study results.
- [ ] Data processing agreement compliant with HIPAA and/or GDPR and/or DPDP Act.
- [ ] Incident response commitments, including notification SLAs.
- [ ] Audit log export capability for the hospital's compliance team.

---

## 8. Using the Tool

The `ethics_framework.py` module implements the scoring logic. The `app.py` Streamlit application provides an interactive checklist and downloadable report. See `README.md` for setup.

---

## 9. References

- HIPAA — US health data privacy and security rule.
- GDPR — EU regulation on personal data and automated decision-making.
- DPDP Act 2023 — India's Digital Personal Data Protection Act.
- FDA SaMD — FDA guidance on Software as a Medical Device.
- WHO — Ethics and governance of AI for health, 2021.
- EU AI Act — classifies medical AI as high-risk.

---

*Prepared as part of the Generative AI curriculum.*
*Gopesh Aggarwal — Roll No 2301730158.*
